← Deal Flow

CTIBIOTECH

Deep
1Rounds
0Articles
General InformationCTIBIOTECH appears to be a deep-tech biotech company focused on cellular or therapeutic innovation, though specific details about location, employee count, and founding date could not be verified through available sources.
Funding & FinancialsNo confirmed funding information could be found for CTIBIOTECH through public sources, suggesting it may be early-stage or operating with limited public disclosure.
Leadership & TeamLeadership information for CTIBIOTECH could not be confirmed from available web sources.
Recent ActivityNo recent notable developments, product launches, or partnerships for CTIBIOTECH could be verified from current public information.

Highlights

Total Raised
1 rounds
Latest Round
$27
May 6, 2026
Stage
deep-tech
Employees
Headquarters
News Coverage
Talent Signals
SEC Filings

Funding History

$27
2026
Strategic
SEC Form D   Editorial
May 6, 2026
$27 millionStrategic · Editorial

3D bioprinting Contract Research, Development, and Manufacturing Organization (CRDMO) announced $27 million investment to launch North American operations and expand bioprinted tissue therapeutics for pharmaceutical and biomedical markets.

Similar Companies 6